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Available online 17 May 2017SOX2 is an important transcription factor involved in pluripotencymaintenance, pluripotent reprogramming and
differentiation towards neural lineages. Here we engineered the previously described HEL24.3 hiPSC to generate
a SOX2 reporter by knocking-in a T2A fused nuclear tdTomato reporter cassette before the STOP codon of the
SOX2 gene coding sequence. CRISPR/SaCas9-mediated stimulation of homologous recombination was utilized
to facilitate faithful targeted insertion. This line accurately reports the expression of endogenous SOX2 and there-
fore constitutes a useful tool to study the SOX2 expression dynamics upon hiPSC culture, differentiation and so-
matic cell reprogramming.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Resource table.nique stem cell line identiﬁer UHi001-A
lternative name of stem cell line HEL24.3-SOX2-ntdT;
HEL24.3-SOX2-ntdT-C9-H5
stitution Biomedicum Stem Cell Center,
University of Helsinki
ontact information of distributor Diego Balboa
ype of cell line hiPSC
rigin HEL24.3 hiPSC described in Trokovic et al. 2015
dditional origin info Sex: Male
ell Source Human foreskin cells (HFFs; CRL-2429, ATCC)
ethod of reprogramming CytoTuneTM-iPS Sendai Reprogramming Kit
(Life Technologies)
ssociated disease Healthy donor
ene/locus SOX2
ethod of modiﬁcation CRISPR/SaCas9
ene correction N/A
ame of transgene or resistance T2A-NLS-tdTomato-F2A-Pac
ducible/constitutive system N/A
ate archived/stock date N/A
ell line repository/bank N/A
thical approval Coordinating Ethics Committee of Helsinki and
Uusimaa Hospital District approved generation
and use of human iPSC (statement nr.
423/13/03/00/08) on April 2009. Human foreskin
cells obtained from ATCC (HFFs; CRL-2429). This is an open access article underResource utility
We generated a SOX2-ntdTomato reporter hiPSC to study the ex-
pression of SOX2 in live cells. This cell line can be utilized formonitoring
SOX2 expression during stem cell maintenance, differentiation, and
reprogramming of differentiated cells derived from this cell line back
to pluripotency.
Resource details
SOX2 is a transcription factor that has important roles in different
stages of mammalian development, especially in stem cell state acquisi-
tion and maintenance, and differentiation to neuroectodermal lineages.
SOX2 is also part of the reprogramming transcription factor set, together
with OCT4, KLF4 and MYC, utilized to reprogram somatic cells to the
pluripotent stage (Takahashi and Yamanaka, 2006).
A SOX2-ntdTomato reporter human induced pluripotent stem cell
line was generated using CRISPR/SaCas9 genome editing technology to
knock-in a T2A-NLS-tdTomato-F2A-Pac reporter cassette before the
STOP codon of the endogenous SOX2 locus (Fig. 1A. tdTomato reporter
cassette targeting strategy. Nuclear localized tdTomato followed by
F2A-puromycin enables selection of recombinant clones. Red arrow-
heads indicate SaCas9-cutting site. Black arrowheads indicate binding
sites for PCR primers used for insertion detection). Donor template,
SaCas9-expressing plasmid and gRNA-transcriptional cassette were de-
livered by electroporation. Puromycin-resistant clones were individual-
ly picked and screened for correct integration by PCR (Fig. 1B. PCR
analysis of reporter cassette insertion in SOX2 locus). Clone number 9the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Generation of a SOX2 reporter hiPSC using CRISPR/SaCas9.
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Table 1
Characterization and validation of HEL24.3-SOX2-ntdT.
Classiﬁcation Test Result Data
Morphology Photography Normal Fig. 1 panel C
Phenotype Immunocytochemisty Staining for SOX2, OCT4, NANOG, TRA1-60 and LIN28 Fig. 1 panel D and E
Flow cytometry TRA-1-60 and TRA-1-81 Fig. 1 panel H
SOX2 ﬂow cytometry Fig. 1 panel K
Genotype Karyotype (G-banding) and
resolution
46, XY
Resolution approx. 400 bands
Fig. 1 panel F
Identity Microsatellite PCR (mPCR) Not performed –
STR analysis StemElite ID System, 9 sites Supplementary ﬁles
Mutation analysis
(IF APPLICABLE)
Sequencing Heterozygous insertion of reporter cassette in SOX2 locus
determined by PCR
Data with author
SaCas9 putative off-target sites analyzed by Sanger sequencing Supplementary ﬁles
Southern Blot OR WGS – –
Microbiology and
virology
Mycoplasma Negative Biochemical luminescence MycoAlert™
Mycoplasma Detection Kit, Lonza. Data with
author
Differentiation
potential
Embryoid body formation OR
Teratoma formation OR Scorecard
Spontaneous embryoid body differentiation. Directed
differentiation to endoderm. Three lineage tissues in teratoma
assay
Fig. 1G, I, J, K and L. See also Trokovic et al. (2015)
Donor screening
(OPTIONAL)
HIV 1 + 2 Hepatitis B, Hepatitis C – –
Genotype
additional info
(OPTIONAL)
Blood group genotyping – –
HLA tissue typing – –
18 D. Balboa et al. / Stem Cell Research 22 (2017) 16–19was subsequently single-cell sorted to ensure clonality of the reporter
cell line. PCR-analysis conﬁrmed reporter cassette heterozygous inser-
tion at the SOX2 locus (data not shown).
HEL24.3-SOX2-ntdT reporter hiPSCs presented bright nuclear red
ﬂuorescent signal in live imaging (Fig. 1C, Bright ﬁeld (BF) and
tdTomato (tdT) live microscopy of a reporter colony). Reporter cell
line characterization by immunocytochemistry for different
pluripotency markers showed overlapping of the nuclear tdTomato sig-
nal with SOX2 (Fig. 1D), OCT4 and NANOG in the nuclei, with LIN28 in
the cytoplasm and TRA-1-60 in the cell membrane (Fig. 1E). Flow cy-
tometry analysis demonstrated expression of pluripotency markers
TRA-1-60 and TRA-1-81 (Fig. 1H). Reporter cells were able toTable 2
Reagents details.
Antibodies used for immunocytochemistry/ﬂow-cytometry
Antibody
Pluripotency markers Rabbit anti-SOX2
Rabbit anti-OCT4
Rabbit anti-NANOG
Rabbit anti-LIN28
Mouse anti-TRA1-81
Mouse anti-TRA1-60
Germ layers Rabbit anti-AFP
Mouse anti-SMA
Mouse anti-TUJ1
Secondary antibodies Donkey anti-Rabbit IgG (H + L), Alexa Fluor 4
Donkey anti-Mouse IgG (H + L), Alexa Fluor 4
Primers
Target
SOX2 end SaCas9 gRNA oligo SOX2 stop codon
SOX2 T7 test PCR SOX2 stop codon
Insertion detection PCR 5′homology arm SOX2 and tdTomato
Insertion detection PCR 3′homology arm Puro and SOX2
Plasmids
PUC19-SOX2-T2A-NLS-tdT-F2A-PURO PCR-cloning
CAG-SaCas9 Cloned from PX601 (Addgene Plasmid #61591differentiate to three germ layers in embryoid body assay (Fig. 1G, en-
dodermmarker alpha fetoprotein, AFP,mesodermmarker smoothmus-
cle actin, SMA, neuroectodermmarker, tubulin beta III, TUJ1). Karyotype
analysis of this clone was normal 46,XY (Fig. 1F).
We evaluated the dynamic expression of the reporter upon differen-
tiation of HEL24.3-SOX2-ntdT cells in vitro. Induction of spontaneous
differentiation as a monolayer or in embryoid-body assay resulted in
gradual reduction in tdTomato ﬂuorescence (BF and tdT livemicroscopy
of differentiated cells in monolayer, Fig. 1I, or as embryoid bodies, Fig.
1J). Similarly, directed differentiation of the reporter cells to deﬁnitive
endoderm showed concomitant reduction in the number of cells ex-
pressing SOX2 and tdTomato (Fig. 1K, ﬂow cytometry of deﬁnitiveDilution Company Cat # and RRID
1:500 Cell Signaling Technology Cat# 3579S, RRID: AB_2195767
1:500 Santa Cruz Biotechnology Cat# sc-9081, RRID: AB_2167703
1:500 Cell Signaling Technology Cat# 4903P, RRID: AB_10829232
1:500 Cell Signaling Technology Cat# 3695P, RRID: AB_10886920
1:50 Thermo Fisher Scientiﬁc Cat# MA1–024, RRID: AB_2536706
1:50 Thermo Fisher Scientiﬁc Cat# MA1–023, RRID: AB_2536699
1:500 Dako Cat# A0008, RRID: AB_2650473
1:400 Sigma-Aldrich Cat# A2547, RRID: AB_476701
1:500 R and D Systems Cat# MAB1195, RRID: AB_357520
88 1:500 Thermo Fisher Scientiﬁc Cat# A-21206, RRID: AB_2535792
88 1:500 Thermo Fisher Scientiﬁc Cat# A-21202, RRID: AB_2535788
Forward/Reverse primer (5′–3′)
GTGGAAAGGACGAAACACCgaaatgggaggggtgcaaaagagGTTTTAGTACTCTGGAAAC
Sox2 h-m F1: GCCCTGCAGTACAACTCCAT
SOX2_3′UTR_R2: tcagAAGCTTCTTCTTTTCACGTTTGCAACTG
Amplicon = 964 bp
SOX2 up_screen_Fw: CTTCGCCTGATTTTCCTCGCG
tdTomato rev2: Gatgacctcctcgcccttgc
Amplicon = 1263 bp
Puro_Fw: CACCAGGGCAAGGGTCTG
SOX2_3′UTR_R1: AGACCACAGAGATGGTTCGC
Amplicon = 850 bp
Deposited in Addgene
) Deposited in Addgene
19D. Balboa et al. / Stem Cell Research 22 (2017) 16–19endodermdifferentiated cells for SOX2 and tdTomato, before differenti-
ation (Day 0 NT) and after 3 days of deﬁnitive endoderm differentiation
(Day 3 DE diff.))
We derived ﬁbroblast-like cells from HEL24.3-SOX2-ntdT by plating
embryoid bodies and prolonged culture. These reporter ﬁbroblastswere
then reprogrammed back to pluripotency using replicative episomal
reprogramming plasmids. The reprogramming process was monitored
daily for the appearance of induced pluripotent stem cell colonies. By
day 8 of reprogramming the ﬁrst epithelial clusters typical of
reprogramming appeared and, by day 12, these clusters started to ex-
press tdTomato. This indicates that endogenous SOX2 transcriptional
activation occurs already at day 12, contributing to the establishment,
stabilization and expansion of the forming hiPSC colonies from that
time point onwards. (Fig. 1L, tdTomato ﬂuorescence and brightﬁeld im-
ages at different time points of the reprogramming process of HEL24.3-
SOX2-ntdT-derived ﬁbroblasts).
Materials and methods
hiPSC maintenance and differentiation
Cells were cultured with E8medium (Life Technologies, A1517001),
on Matrigel (BD Biosciences)-coated plates and passaged using 5 mM
EDTA (Life Technologies, 15575-038) as a dissociation agent. Cells
were spontaneously differentiated in monolayer and embryoid bodies
by culturing them on hES media (KnockOut DMEM (Gibco) supple-
mented with 20% KO serum replacement (Gibco), 1% GlutaMAX
(Gibco), 0.1 mM beta-mercaptoethanol, 1% nonessential amino acids
(Gibco)) without FGF2. Embryoid bodies were generated as described
elsewhere (Balboa et al., 2015). Deﬁnitive endoderm-differentiation
was induced using 100 ng/mL ActivinA and 3 μM CHIR99021
(Tocris,4423) as described elsewhere (Saarimäki-Vire et al., 2017).
Gene targeting of SOX2 locus in HEL24.3
Staphylococcus aureus Cas9 was used as the guide RNA-targeted en-
donuclease to stimulate reporter donor template homologous recombi-
nation in the insertion site before SOX2 stop codon (Ran et al., 2015).
SaCas9 was cloned from pX601 plasmid (a gift from Feng Zhang,
Addgene plasmid #61591) into a vector with a strong CAG promoter
to enable robust expression in hiPSC (CAG-SaCas9, deposited in
Addgene). SaCas9 guideRNAs targeting SOX2 stop codonwere designed
using Benchling. Guide-RNA transcriptional cassettes were assembled
by PCR as previously described (Balboa et al., 2015). pUC19-SOX2-
T2A-NLS-tdT-F2A-PURO donor template plasmid (deposited in
Addgene) was cloned by PCR. tdTomato sequence was cloned from
pCSCMV:tdTomato (a gift from Gerhart Ryffel, Addgene plasmid
#30530). Homology arm lengths are 951 bp for 5′-homology-arm and
478 bp for 3′-homology-arm.
Two million HEL24.3 hiPSCs were electroporated with 6 μg CAG-
SaCas9 plasmid, 2 μg pUC19-SOX2-T2A-NLS-tdT-F2A-PURO donor tem-
plate plasmid and 500 ng of SOX2 end SaCas9 gRNA PCR product.
Electroporated cells were plated on Matrigel-coated plates on E8 con-
taining 5 μm ROCK inhibitor (Y-27632 2HCl, Selleckchem). ROCKinhibitor was removed after 24 h, and selection started with 0.3–0.5
μg/mL puromycin 72 h after electroporation. After the cells were select-
ed for 8 days, ﬂuorescent colonies were picked to 96-well plates. Elec-
troporation, expansion, screening and single-cell sorting were
performed as described elsewhere (Saarimäki-Vire et al., 2017). Karyo-
type analysis based on chromosomal G-banding was done at Yhtyneet
Medix Laboratories, Helsinki, Finland.
Immunocytochemistry and ﬂow cytometry
Brieﬂy, cells were ﬁxed in 4% PFA for 15 min, 0.5% Triton X-100 in
1× PBS was used for permeabilization. Then cells were blocked with
UltraV block (ThermoFisher) for 10 min, and incubated overnight at
4 °C in 0.1%-Tween-PBS-containing diluted primary antibodies. After
2–3× PBS washes, cells were incubated with secondary antibodies.
See Table 2, list of antibodies. Flow cytometry was performed as
described in Saarimäki-Vire et al. (2017). (See Table 1.)
Pluripotent reprogramming
Reporter iPSCs were ﬁrst differentiated as EBs and plated in ﬁbro-
blast medium (Dulbecco's modiﬁed Eagle's medium (DMEM; Life Tech-
nologies) containing 10% fetal bovine serum (FBS; Life Technologies),
2 mM GlutaMAX (Life Technologies), and 100 g/mL penicillin-strepto-
mycin (Life Technologies)). After 8 passages in culture, 1 million
ﬁbroblast-like cells were electroporated with 6 μg episomal
reprogramming plasmids (pCXLE-hOCT3/4-shp53, pCXLE-hSK and
pCXLE-hUL gift from Shinya Yamanaka; Addgene plasmids #27077,
#27078 and #27080). Cells were plated on Matrigel-coated dishes and
cultured in 1:1 mixture of hES and ﬁbroblast media supplemented
with sodium butyrate (0.25 mM; Sigma).
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2017.05.005.
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